Back
Compagnie Financiere Richemont SA Vs. Neurogene Industry Stock Comparison
Sell
37
CFRUY
Compagnie Financiere Richemont SA
Last Price:
13.55
Seasonality Move:
9.31%
Sell
5
NGNE
Neurogene
Last Price:
39.96
Seasonality Move:
50.43%
Sell
37
Compagnie Financiere Richemont SA (CFRUY)
is a Sell
Is Compagnie Financiere Richemont SA a Buy, Sell or Hold?
- The current Compagnie Financiere Richemont SA [CFRUY] share price is $13.31. The Score for CFRUY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- CFRUY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CFRUY Stock Price Chart
What is Compagnie Financiere Richemont SA's stock price today?
-
The Compagnie Financiere Richemont SA share price today is $13.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CFRUY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CFRUY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.35 | Sell |
Relative Strength Index (14 RSI): | 32.32 | Sell |
Chaikin Money Flow: | 368036 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.95 - 15.05) | Sell |
Bollinger Bands (100): | (14.24 - 15.64) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.3 | Buy |
Relative Strength Index (14 RSI): | 39.1 | Sell |
Chaikin Money Flow: | -346626 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.29 - 61.53) | Sell |
Bollinger Bands (100): | (34.11 - 50.51) | Sell |
CFRUY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.95 | Sell |
20-day SMA: | 14.36 | Sell |
50-day SMA: | 14.55 | Sell |
200-day SMA: | 15.11 | Sell |
8-day EMA: | 13.81 | Sell |
20-day EMA: | 14.24 | Sell |
50-day EMA: | 14.59 | Sell |
200-day EMA: | 14.79 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.39 | Sell |
20-day SMA: | 53.17 | Sell |
50-day SMA: | 46.66 | Sell |
200-day SMA: | 38.93 | Buy |
8-day EMA: | 54.03 | Sell |
20-day EMA: | 53.18 | Sell |
50-day EMA: | 48.36 | Sell |
200-day EMA: | 38.47 | Buy |
Compagnie Financiere Richemont SA Earnings Growth & CFRUY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.01 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Compagnie Financiere Richemont SA Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |